A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group

[1]  T. Pawlik,et al.  A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium , 2017, Annals of Surgical Oncology.

[2]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[3]  T. Pawlik,et al.  Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[4]  J. Sicklick,et al.  Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group. , 2016, Journal of the American College of Surgeons.

[5]  E. Kebebew,et al.  Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study , 2016, World Journal of Surgery.

[6]  T. Pawlik,et al.  A novel pathology-based preoperative risk score to predict distant and locoregional residual disease and survival for incidentally discovered gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium. , 2016 .

[7]  G. Spolverato,et al.  Factors Associated With Recurrence and Survival in Lymph Node–negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative , 2015, Annals of surgery.

[8]  R. Libé.  Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment , 2015, Front. Cell Dev. Biol..

[9]  D. Winchester,et al.  A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. , 2014, Surgery.

[10]  Ning Li,et al.  Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease. , 2014, Surgery.

[11]  C. Wood,et al.  Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. , 2013, European journal of endocrinology.

[12]  M. Bloomston,et al.  Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  S. Maithel,et al.  The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[14]  T. Giordano,et al.  Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade , 2010, Langenbeck's Archives of Surgery.

[15]  Jong Hoon Kim,et al.  Prognostic Significance of Lymphovascular Invasion in Sporadic Colorectal Cancer , 2010, Diseases of the colon and rectum.

[16]  F. Montorsi,et al.  The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. , 2010, European journal of cancer.

[17]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[18]  Jeffrey E. Lee,et al.  Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma , 2009, Cancer.

[19]  D. Bentrem,et al.  Adrenocortical carcinoma in the United States , 2008, Cancer.

[20]  Electron Kebebew,et al.  Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress? , 2006, World Journal of Surgery.

[21]  Y. Tachimori,et al.  Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases , 2006, Modern Pathology.

[22]  Michael Gnant,et al.  Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer , 2004, Annals of surgery.

[23]  M. Brennan,et al.  Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma , 1999, Annals of Surgical Oncology.

[24]  L. Delclos,et al.  Early stage I adenocarcinoma of the uterine cervix: Treatment results in patients with tumors ≤4 cm in diameter , 1991 .

[25]  M. Gönen,et al.  Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases , 2012, Annals of Surgical Oncology.

[26]  L. Delclos,et al.  Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. , 1991, Gynecologic oncology.